Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers | Synapse

March 19, 2019Open Access

Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers

STStefano TrebeschiDutch Cancer Society SDSilvia Girolama DragoAzienda Ospedaliera San Gerardo NBNicolai J. BirkbakAarhus University

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

These results indicate that radiographic characteristics of lesions on standard-of-care imaging may function as noninvasive biomarkers for response to immunotherapy, and may show utility for improved patient stratification in both neoadjuvant and palliative settings.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Trebeschi et al. (Tue,) studied this question.

synapsesocial.com/papers/69d89ba305ee2ba81dbefdf9 https://doi.org/https://doi.org/10.1093/annonc/mdz108

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Clonal evolution in cancer2012 · 3,216 citations
2Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial2015 · 2,669 citations
3Proceedings of the 2020 Genetic and Evolutionary Computation Conference2020 · 180 citations
4The tumor microenvironment and its role in promoting tumor growth2008 · 2,390 citations
5Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy2013 · 655 citations